Analysts’ Viewpoint on Brazil Parenteral Nutrition Market Scenario
Pharmaceutical compounding companies in the Brazil parenteral nutrition market are increasing the availability of life-saving therapeutic products amid the ongoing coronavirus outbreak to support vulnerable patients. Over the years, incidences of PN-related complications have reduced significantly. A key factor underpinning this positive change is the advent of technologically-advanced devices in central vascular access devices. On the other hand, indications for parenteral nutrition have grown substantially, thus expanding the canvas for players in the Brazil parenteral nutrition market to explore. The marked prevalence of metabolic disorders and end-of-life kidney diseases globally is a key driver for artificial nutrition uptake. Thus, companies should innovate in new admixture formulations to improve patient outcomes.
The requirement of artificial nutrition in patients with chronic diseases is an important driver that has spurred product innovations. Such trends are translating into revenue opportunities for stakeholders in the Brazil parenteral nutrition market. The use of parenteral nutrition (PN) as a life-sustaining therapy in patients with chronic short bowel syndrome and severe gastro-intestinal disorders is increasing, especially when other alternatives of artificial nutrition are not well tolerated in patients.
A growing body of studies, including randomized clinical trials, has been conducted on comparing the efficacy of parenteral nutrition with enteral nutrition. Some of the study findings suggest that parenteral nutrition therapies play a positive role in reducing mortality in critically-ill patients. Moreover, advancements in admixture formulations have resulted in making parenteral nutrition more physiologically attractive to the target patients.
Even though the COVID-19 pandemic has subsided in Brazil, the movement of goods and services is relatively slow. Hence, companies in the Brazil parenteral nutrition market are taking support of government stimulus packages to stay financially afloat amid the ongoing pandemic.
The scarcity of pharmaceutical compounds and other raw materials for intravenous devices is likely due to production stoppages and labor shortages. Nevertheless, manufacturers should increase their local production capabilities to reduce dependence on other countries for raw materials during uncertain trends in imports and exports. They should foster balanced relationship with suppliers and ecosystem partners to ensure robust and enable alternative supply chains.
The inappropriate usage of parenteral nutrition maximizes the potential risk of adverse events such as liver dysfunction, refeeding syndrome, particulate contamination, and catheter infections to the patients undergoing the therapy. This factor is restraining growth of the Brazil parenteral nutrition market. For instance, an article published by the American Society for Nutrition in 2014 indicated that long-term parenteral nutrition therapy significantly increases the risk of metabolic complications and liver disease in patients. Thus, innovations in catheters and advancements in technologies used for vascular access in such patients hold promising potentials to improve patient quality of life. Proper training and best healthcare practices are being adopted in facilities to improve patient outcomes.
Based on nutrition type, pharmaceutical compounding companies in the Brazil parenteral nutrition market are experimenting in admixtures induced with vitamins, single dose amino acids, carbohydrates, parenteral lipid emulsions, trace elements, electrolytes, and minerals. The single dose amino acid segment held major share of the parenteral nutrition market in Brazil in 2020. The segment is expected to dominate the market during the forecast period. Parenteral amino acids are becoming commonplace in critical care situations such as hepatic failure, burns, premature infants, post-surgical cases, complete bowel obstruction, severe catabolism, renal disorders & prolonged coma.
An alarming rise in the number of premature births requiring long term care is a key factor attributed to the growth of the Brazil parenteral nutrition market. Advancements in technologies used for vascular access in such patients has spurred the acceptance of parenteral nutrition in such patients. Greater focus on reducing catheter-related bloodstream infections has positively influenced the market dynamics for parenteral nutrition.
Parenteral nutrition is considered an essential treatment therapy to provide adequate nutrition support to critically ill patients. The incidence of malnutrition is increasing rapidly due to poor dietary habits in Brazil and high poverty rate in developing regions. The rise in cases of malnutrition among the geriatric population is fueling the demand for parenteral nutrition products. Moreover, protein-energy malnutrition is found to be a common state in elderly institutionalized people.
|
Attribute |
Detail |
|
Market Size Value in 2020 (Base Year) |
US$ 157.97 Mn |
|
Market Forecast Value in 2031 |
US$ 311.08 Mn |
|
Growth Rate (CAGR) |
6.6% |
|
Forecast Period |
2021–2031 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview. |
|
Format |
Electronic (PDF) |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Brazil Parenteral Nutrition Market – Segmentation
TMR’s study on the parenteral nutrition market in Brazil includes information divided into four segments: nutrition type, consumer, end-user, and region. Changing industry trends and other market dynamics associated with these segments of the parenteral nutrition market in Brazil are discussed in detail.
| Nutrition Type |
|
| Consumer |
|
| End-user |
|
| Region |
|
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Brazil Parenteral Nutrition Market
4. Market Overview
4.1. Introduction
4.1.1. Nutrition Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Brazil Parenteral Nutrition Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Regulatory Scenario
5.2. Disease Prevalence & Incidence Rate
5.3. Key Industry Events
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Brazil Parenteral Nutrition Market Analysis and Forecast, by Nutrition Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value & Volume Forecast, by Nutrition Type, 2017–2031
6.3.1. Carbohydrates
6.3.2. Parenteral Lipid Emulsions
6.3.3. Single Dose Amino Acid
6.3.4. Trace Elements, Electrolytes, and Mineral
6.3.5. Vitamins
6.4. Market Attractiveness Analysis, by Nutrition Type
7. Brazil Parenteral Nutrition Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value & Volume Forecast, by End-user, 2017–2031
7.3.1. Hospitals
7.3.2. Clinics
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Brazil Parenteral Nutrition Market Analysis and Forecast, by Consumer
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value & Volume Forecast, by Consumer, 2017–2031
8.3.1. Children
8.3.2. Adults
8.4. Market Attractiveness Analysis, by Consumer
9. Brazil Parenteral Nutrition Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value & Volume Forecast, by Region
9.2.1. North Brazil
9.2.2. Northeast Brazil
9.2.3. South Brazil
9.2.4. Southeast Brazil
9.2.5. Center-west Brazil
10. North Brazil Parenteral Nutrition Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Nutrition Type, 2017–2031
10.2.1. Carbohydrates
10.2.2. Parenteral Lipid Emulsions
10.2.3. Single Dose Amino Acid
10.2.4. Trace Elements, Electrolytes, and Mineral
10.2.5. Vitamins
10.3. Market Value & Volume Forecast, by End-user, 2017–2031
10.3.1. Hospitals
10.3.2. Clinics
10.3.3. Others
10.4. Market Value & Volume Forecast, by Consumer, 2017–2031
10.4.1. Children
10.4.2. Adults
10.5. Market Attractiveness Analysis
10.5.1. By Nutrition Type
10.5.2. By End-user
10.5.3. By Consumer
11. Northeast Brazil Parenteral Nutrition Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Nutrition Type, 2017–2031
11.2.1. Carbohydrates
11.2.2. Parenteral Lipid Emulsions
11.2.3. Single Dose Amino Acid
11.2.4. Trace Elements, Electrolytes, and Mineral
11.2.5. Vitamins
11.3. Market Value & Volume Forecast, by End-user, 2017–2031
11.3.1. Hospitals
11.3.2. Clinics
11.3.3. Others
11.4. Market Value & Volume Forecast, by Consumer, 2017–2031
11.4.1. Children
11.4.2. Adults
11.5. Market Attractiveness Analysis
11.5.1. By Nutrition Type
11.5.2. By End-user
11.5.3. By Consumer
12. South Brazil Parenteral Nutrition Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Nutrition Type, 2017–2031
12.2.1. Carbohydrates
12.2.2. Parenteral Lipid Emulsions
12.2.3. Single Dose Amino Acid
12.2.4. Trace Elements, Electrolytes, and Mineral
12.2.5. Vitamins
12.3. Market Value & Volume Forecast, by End-user, 2017–2031
12.3.1. Hospitals
12.3.2. Clinics
12.3.3. Others
12.4. Market Value & Volume Forecast, by Consumer, 2017–2031
12.4.1. Children
12.4.2. Adults
12.5. Market Attractiveness Analysis
12.5.1. By Nutrition Type
12.5.2. By End-user
12.5.3. By Consumer
13. Southeast Brazil Parenteral Nutrition Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Nutrition Type, 2017–2031
13.2.1. Carbohydrates
13.2.2. Parenteral Lipid Emulsions
13.2.3. Single Dose Amino Acid
13.2.4. Trace Elements, Electrolytes, and Mineral
13.2.5. Vitamins
13.3. Market Value & Volume Forecast, by End-user, 2017–2031
13.3.1. Hospitals
13.3.2. Clinics
13.3.3. Others
13.4. Market Value & Volume Forecast, by Consumer, 2017–2031
13.4.1. Children
13.4.2. Adults
13.5. Market Attractiveness Analysis
13.5.1. By Nutrition Type
13.5.2. By End-user
13.5.3. By Consumer
14. Center-west Brazil Parenteral Nutrition Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value & Volume Forecast, by Nutrition Type, 2017–2031
14.2.1. Carbohydrates
14.2.2. Parenteral Lipid Emulsions
14.2.3. Single Dose Amino Acid
14.2.4. Trace Elements, Electrolytes, and Mineral
14.2.5. Vitamins
14.3. Market Value & Volume Forecast, by End-user, 2017–2031
14.3.1. Hospitals
14.3.2. Clinics
14.3.3. Others
14.4. Market Value & Volume Forecast, by Consumer, 2017–2031
14.4.1. Children
14.4.2. Adults
14.5. Market Attractiveness Analysis
14.5.1. By Nutrition Type
14.5.2. By End-user
14.5.3. By Consumer
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2020
15.3. Market Footprint Analysis
15.3.1. By Region
15.3.2. By Nutrition Type
15.4. Competitive Business Strategies
15.5. Company Profiles
15.5.1. B. Braun Melsungen AG
15.5.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.1.2. Product Portfolio
15.5.1.3. SWOT Analysis
15.5.1.4. Strategic Overview
15.5.2. Fresenius Kabi AG
15.5.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.2.2. Product Portfolio
15.5.2.3. SWOT Analysis
15.5.2.4. Strategic Overview
15.5.3. Baxter
15.5.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.3.2. Product Portfolio
15.5.3.3. SWOT Analysis
15.5.3.4. Strategic Overview
15.5.4. Drip Hydration
15.5.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.4.2. Product Portfolio
15.5.4.3. SWOT Analysis
15.5.4.4. Strategic Overview
15.5.5. REVIV
15.5.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.5.2. Product Portfolio
15.5.5.3. SWOT Analysis
15.5.5.4. Strategic Overview
15.5.6. Eurofarma
15.5.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.6.2. Product Portfolio
15.5.6.3. SWOT Analysis
15.5.6.4. Strategic Overview
15.5.7. Nestlé Health Science
15.5.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.7.2. Product Portfolio
15.5.7.3. SWOT Analysis
15.5.7.4. Strategic Overview
15.5.8. Farmoterápica
15.5.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.8.2. Product Portfolio
15.5.8.3. SWOT Analysis
15.5.8.4. Strategic Overview
List of Tables
Table 01: South Brazil Parenteral Nutrition Market Value (US$ Mn) Forecast, by Nutrition Type, 2017–2031
Table 02: South Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2017–2031
Table 03: South Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2017–2031
Table 04: North Brazil Parenteral Nutrition Market Value (US$ Mn) Forecast, by Nutrition Type, 2017–2031
Table 05: North Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2017–2031
Table 06: Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2017–2031
Table 07: Center-west Brazil Parenteral Nutrition Market Value (US$ Mn) Forecast, by Nutrition Type, 2017–2031
Table 08: Center-west Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2017–2031
Table 09: Center-west Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2017–2031
List of Figures
Figure 01: Brazil Parenteral Nutrition Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Brazil Parenteral Nutrition Market Value Share, by Nutrition Type, 2020
Figure 03: Brazil Parenteral Nutrition Market Value Share, by Consumer, 2020
Figure 04: Brazil Parenteral Nutrition Market Value Share, by End-user, 2020
Figure 05: Brazil Parenteral Nutrition Market Value Share, by Region, 2020
Figure 06: Brazil Parenteral Nutrition Market Value Share Analysis, by Nutrition Type, 2020 and 2031
Figure 07: Brazil Parenteral Nutrition Market Attractiveness Analysis, by Nutrition Type, 2021–2031
Figure 08: Brazil Parenteral Nutrition Market Revenue (US$ Mn), by Carbohydrates, 2017–2031
Figure 09: Brazil Parenteral Nutrition Market Revenue (US$ Mn), by Parenteral Lipid Emulsions, 2017–2031
Figure 10: Brazil Parenteral Nutrition Market Revenue (US$ Mn), by Single Dose Amino Acids, 2017–2031
Figure 11: Brazil Parenteral Nutrition Market Revenue (US$ Mn), by Trace Elements, Electrolytes, & Minerals, 2017–2031
Figure 12: Brazil Parenteral Nutrition Market Value (US$ Mn), by Vitamins, 2017–2031
Figure 13: Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2020 and 2031
Figure 14: Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2021–2031
Figure 15: Brazil Parenteral Nutrition Market Revenue (US$ Mn), by Children, 2017–2031
Figure 16: Brazil Parenteral Nutrition Market Revenue (US$ Mn), by Adults, 2017–2031
Figure 17: Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2020 and 2031
Figure 18: Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2021–2031
Figure 19: Brazil Parenteral Nutrition Market Revenue (US$ Mn), by Hospitals, 2017–2031
Figure 20: Brazil Parenteral Nutrition Market Revenue (US$ Mn), by Clinics, 2017–2031
Figure 21: Brazil Parenteral Nutrition Market Value (US$ Mn), by Others, 2017–2031
Figure 22: Brazil Parenteral Nutrition Market Value Share Analysis, by Region, 2020 and 2031
Figure 23: Brazil Parenteral Nutrition Market Analysis, by Region
Figure 24: Southeast Brazil Parenteral Nutrition Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 25: Southeast Brazil Parenteral Nutrition Market Value Share Analysis, by Nutrition Type, 2020 and 2031
Figure 26: Southeast Brazil Parenteral Nutrition Market Attractiveness Analysis, by Nutrition Type, 2021–2031
Figure 27: Southeast Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2020 and 2031
Figure 28: Southeast Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2021–2031
Figure 29: Southeast Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2020 and 2031
Figure 30: Southeast Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2021–2031
Figure 31: Northeast Brazil Parenteral Nutrition Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 32: Northeast Brazil Parenteral Nutrition Market Value Share Analysis, by Nutrition Type, 2020 and 2031
Figure 33: Northeast Brazil Parenteral Nutrition Market Attractiveness Analysis, by Nutrition Type, 2021–2031
Figure 34: Northeast Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2020 and 2031
Figure 35: Northeast Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2021–2031
Figure 36: Northeast Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2020 and 2031
Figure 37: Northeast Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2021–2031
Figure 38: South Brazil Parenteral Nutrition Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 39: South Brazil Parenteral Nutrition Market Value Share Analysis, by Nutrition Type, 2020 and 2031
Figure 40: South Brazil Parenteral Nutrition Market Attractiveness Analysis, by Nutrition Type, 2021–2031
Figure 41: South Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2020 and 2031
Figure 42: South Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2021–2031
Figure 43: South Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2020 and 2031
Figure 44: South Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2021–2031
Figure 45: North Brazil Parenteral Nutrition Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 46: North Brazil Parenteral Nutrition Market Value Share Analysis, by Nutrition Type, 2020 and 2031
Figure 47: North Brazil Parenteral Nutrition Market Attractiveness Analysis, by Nutrition Type, 2021–2031
Figure 48: North Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2020 and 2031
Figure 49: North Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2021–2031
Figure 50: North Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2020 and 2031
Figure 51: North Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2021–2031
Figure 52: Center-west Brazil Parenteral Nutrition Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 53: Center-west Brazil Parenteral Nutrition Market Value Share Analysis, by Nutrition Type, 2020 and 2031
Figure 54: Center-west Brazil Parenteral Nutrition Market Attractiveness Analysis, by Nutrition Type, 2021–2031
Figure 55: Center-west Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2020 and 2031
Figure 56: Center-west Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2021–2031
Figure 57: Center-west Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2020 and 2031
Figure 58: Center-west Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2021–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Brazil Parenteral Nutrition Market
